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S U M M A R Y
Objective: To characterize the potential effects of Helicobacter infections on growth velocity in low
socioeconomic status young children in a developing country.
Methods: Children were recruited in poor suburbs of Quito, Ecuador. Normally nourished, mildly and
substantially malnourished children (deﬁned using weight-for-age Z-scores at recruitment) formed
equal strata. Six height and weight measurements were collected during one year. Enrollment and exit
serum samples were analyzed for anti-Helicobacter IgG and exit non-diarrheal feces tested for
Helicobacter antigen.
Results: Among 124 participants (enrollment age 19  9 months), 76 (61%) excreted fecal antigen at exit
(were infected). Of these, 44 were seropositive at least once (chronic infections) and 32 tested seronegative
both times (new or acute phase infections). The adjusted linear growth velocity during follow-up in children
with new infections was reduced by 9.7 (3.8, 15.6) mm/year compared to uninfected controls and 6.4 (0.0,
12.9) mm/year compared to children with chronic infections. The effects of Helicobacter infections on
ponderal growth were not signiﬁcant.
Conclusion: These results suggest that linear growth velocity is reduced in young children during the
initial phase of Helicobacter infection.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Helicobacter pylori is an important pathogen that can cause
gastritis, gastric and duodenal ulcers, and gastric cancer.1 This
bacterium is uniquely adapted to chronically infect the human
stomach. It elicits a predominantly Th1-type immune response,
which may be responsible for gastritis symptoms.2,3 Infections
typically spread through person-to-person contacts,2 but water-
borne transmissionmay also occur.4 In developing countries, most
people acquire infection in early childhood.2,5 The acquisition of
infection is often followed by transient acute gastritis symptoms
and depressed gastric acid secretion.2,6,7 Helicobacter has been
shown to impair absorption of nutrients and vitamins,8,9 and
retard growth in children in developing countries.6,10–13
Helicobacter-infected individuals excrete Helicobacter antigen.
Fecal antigen tests have excellent sensitivity and speciﬁcity as* Corresponding author. Tel.: +1 513 407 5491.
E-mail address: andrey.egorov@tufts.edu (A.I. Egorov).
1201-9712/$36.00 – see front matter . Published by Elsevier Ltd on behalf of Internatio
doi:10.1016/j.ijid.2010.03.013compared to more invasive diagnostic tests in children.14–18
Helicobacter infection also induces strong antibody responses.19
Animal experiments have demonstrated that the development of
an antibody response reduces gastritis symptoms.20 In humans,
IgG seroconversion occurs several months post-infection.21,22 This
time lag between infection and IgG seroconversion has been
utilized to deﬁne acute (prior to seroconversion) and chronic (after
seroconversion) phases of infection.23–25 Antibodies also persist
following spontaneous eradication of Helicobacter, which some-
times occurs in children.26
The objective of this study was to evaluate the effects of both
chronic and acute H. pylori infections on linear and ponderal
growth in young Ecuadorian children.
2. Methods
This prospective study was nested within a larger study of the
effects of micronutrient (vitamin A and/or zinc) supplementation
in young children (manuscript in review). The parent study wasnal Society for Infectious Diseases.
A.I. Egorov et al. / International Journal of Infectious Diseases 14 (2010) e788–e791 e789registered at www.ClinicalTrials.gov (NCT00228254). For that
parent study, children aged 6 to 36 months were recruited in poor
suburbs of Quito, Ecuador at community recruitment sessions in
April–May 2002 and 2003. Weight-for-age and height-for-age
standard deviation scores or Z-scores (WAZ and HAZ) were
estimated using the US National Center for Health Statistics
reference data. Malnourished children were intentionally over-
sampled: substantially malnourished (WAZ  2), mildly mal-
nourished (2 <WAZ  1), and normally nourished children
(WAZ > 1) formed one-third each of the study population.
Severely malnourished children (weight < 60% of the age-adjusted
norm) were excluded from the study and referred to nutritional
rehabilitation centers. After recruitment, children were randomly
assigned into intervention or placebo groups, and followed for
approximately one year starting from June. This manuscript
presents data collected from the placebo group.
A household survey was conducted at enrollment to assess
demographic, socioeconomic, and hygiene characteristics. Study
nurses visited all children during follow-up four times per week to
look for respiratory and diarrheal symptoms. Growth parameters
were measured at enrollment and approximately every 10 weeks
thereafter for a total of six measurements per child. Blood samples
were collected from each child after overnight fasting at
enrollment and exit to measure micronutrient levels.
All aspects of this nested study were approved by the ethics
committees of Tufts University School of Medicine in Boston
and the Corporacio´n Ecuatoriana de Biotecnologı´a in Quito.
Separate informed consents were obtained from parents or
guardians of each participating child for the parent study and
nested study.
Leftover serum samples were analyzed for anti-Helicobacter
IgG responses using commercial ELISA test kits procured from IBL
Immuno-Biological Laboratories (Hamburg, Germany). These kits
included a microplate coated with a mixture of puriﬁed bacterial
proteins containing CagA and VacA antigens, secondary horserad-
ish peroxidase-conjugated anti-human antibody solution, and a set
of standards. The optical density values for anti-Helicobacter IgG
responses were converted into arbitrary unit concentrations (U/
ml) and dichotomized using microplate-speciﬁc cut-off values. At
the end of the follow-up (study exit), the participants of this nested
study also provided one non-diarrheal fecal sample, which was
analyzed for excreted Helicobacter antigen using a sandwich
monoclonal antibody-based ELISA assay (Hp StARTM, DAKO A/S,
Glostrup, Denmark). The Helicobacter fecal test results were
dichotomized at the optical density value of 0.15 as per the
manufacturer’s instructions. All laboratory tests were conducted at
the Catholic University of Ecuador (Pontiﬁcia Universidad Cato´lica
del Ecuador) in Quito. Samples were collected from households byTable 1
Descriptive statistics of the study population
Factor n (%) of
participants
Mean (SD) age
at enrollment,
months
Mean (SD)
height at
enrollment
All participants 124 (100) 19.0 (8.5) 758 (82)
Gender
Boys 73 (58.9) 19.3 (8.4) 766 (78)
Girls 51 (41.1) 18.7 (8.6) 747 (86)
Nutritional status
Substantially malnourished 37 (29.8) 20.3 (8.1) 750 (68)
Mildly malnourished 45 (36.3) 19.9 (7.6) 767 (70)
Normally nourished 42 (33.9) 16.9 (9.4) 756 (103)
H. pylori infection
New infection 32 (25.8) 18.3 (8.2) 753 (84)
Chronic infection 44 (35.5) 20.6 (8.8) 766 (76)
Not infected 48 (38.7) 18.1 (8.3) 755 (86)
SD, standard deviation.study nurses, delivered to the laboratory in refrigerated containers,
and stored at 20 8C until analysis.
Children were classiﬁed as infected or non-infected based on
the results of their fecal antigen test. Infected childrenwere further
classiﬁed based on their serology as having (1) chronic infections
(tested seropositive at enrollment and/or exit) or (2) new or acute
phase infections (tested seronegative both times).
Data were analyzed using SAS v. 9.2 (SAS Institute, Cary, NC,
USA). Demographic and socioeconomic risk factors for Helicobac-
ter infection were analyzed using logistic regression. Data on
growth during follow-up were analyzed using mixed effect
regression models using SAS procedure GLIMMIX.
3. Results
Only children from the placebo groupwho submitted their non-
diarrheal fecal samples at the study exit were included in this
analysis (N = 124). Of these, 26 children represented the 2002–
2003 cohort of the parent study and 98 children represented the
2003–2004 cohort (20% and 71%, respectively, of the placebo arm
of each cohort). The breakdown of the study population by gender,
nutritional status strata, and Helicobacter infection status is
presented in Table 1.
The age at enrollment ranged from 4.6 to 35.7 months,
average  standard deviation 19.0  8.5 months. The average dura-
tion of follow-up (interval between the ﬁrst and the last anthropo-
metric measurement) was 388 days, standard deviation 26 days,
range 277–413 days. The average age at study exit was 31.8 months.
Normally nourished children were, on average, younger than
substantially malnourished children, while children who were not
infected and children who had acute phase infections were, on
average, younger than children with chronic phase infections
(Table 1).
Seventy-six (61%) study participants were infected with H.
pylori (excreted antigen) at study exit (acute and chronic infections
combined). A detailed breakdown of the study population by
infection status and serology is presented in Table 2. Among 44
childrenwhowere classiﬁed as chronically infected, 41 (93%) were
seropositive at exit. Among 48 childrenwhowere not infectedwith
Helicobacter, only four (8%) were seropositive at exit.
Prevalence rates of Helicobacter infection at study exit were
73% in substantially malnourished, 47% in mildly malnourished,
and 67% in normally nourished children. Although the odds of
infection in mildly malnourished children were signiﬁcantly
smaller than in normally nourished controls (p = 0.03), the
inconsistent pattern with greater odds of infection in substantially
malnourished children suggests that this observed associationwas
due to a random effect. Crowded living conditions (three or more, mm
Mean (SD)
height-for-age
Z-score at enrollment
Mean (SD)
linear growth
velocity, mm/year
Mean (SD)
ponderal growth
velocity, kg/year
1.77 (1.04) 97 (22) 2.17 (0.88)
1.82 (1.13) 94 (22) 2.13 (1.09)
1.71 (0.90) 99 (27) 2.18 (0.53)
2.44 (0.69) 92 (21) 2.15 (0.70)
1.87 (0.84) 92 (21) 2.19 (1.23)
1.08 (1.06) 103 (28) 2.10 (0.59)
1.87 (1.19) 92 (24) 2.08 (0.53)
1.90 (1.00) 94 (25) 2.09 (0.49)
1.59 (0.95) 100 (24) 2.25 (1.30)
Table 2
Detailed breakdown of the study population by infection status and serology
Infection status
category
Fecal antigen test Serum test at enrollment Serum test at exit n % of children in infection
status category
Acute phase Positive Negative Negative 32 100%
Chronic phase Positive Positive Negative 3 7%
Positive Negative Positive 19 43%
Positive Positive Positive 22 50%
Subtotal for category 44 100%
Not infected Negative Negative Negative 36 75%
Negative Positive Negative 8 17%
Negative Negative Positive 3 6%
Negative Positive Positive 1 2%
Subtotal for category 48 100%
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with Helicobacter infection (positive fecal test) in logistic
regression analysis: odds ratio 2.67 (95% conﬁdence interval (CI)
1.04, 6.91; p = 0.04), adjusting for nutritional status strata and age.
Preliminary mixed effect regression analysis at the model
development stage demonstrated that adjusted growth velocities
during follow-upwere similar in all three nutritional status strata.
Therefore, interaction terms between nutritional status and time
were not included in the ﬁnal model. Episodes of diarrhea or
respiratory illness during follow-up, as well as crowded living
conditions, were not signiﬁcantly associated with growth veloci-
ty. Therefore, these variables were also not included in the ﬁnal
model. Height at enrollment and growth velocity in children who
tested seropositive at least once but had negative fecal antigen
test at exit (eradicated Helicobacter infection) did not differ
signiﬁcantly or substantially from those in children who had all
fecal and serological tests negative (p > 0.5 for both tests). This
conﬁrmed that including all fecal test-negative children in the
control group irrespective of their serological status was
appropriate.
The ﬁnal mixed effect model for linear growth included random
effects for intercept, age, and age squared. The main effects are
presented in Table 3. The non-linear effect of age on linear growth
was modeled using a cubic polynomial. Indicator variables for
gender and nutritional status strata were used to model the effects
of these parameters on height at enrollment. Girls were
signiﬁcantly shorter and lighter than boys; substantially malnour-
ished and mildly malnourished children were signiﬁcantly shorter
and lighter than normally nourished children.
The predicted average linear growth velocity in children who
were 19months old at enrollment (average age of the participants)
and remained free of Helicobacter infections (all tests negative)Table 3
Results of linear mixed effect regression analysis of the effects of Helicobacter pylori
infections on linear growth in Ecuadorian children
Variable Effect estimate (95% CI) p-Value
Age (years) 187.0 (168.0, 206.0) <0.0001
Age2 32.2 (41.5, 22.9) <0.0001
Age3 3.2 (1.8, 4.7) <0.0001
Gender
Male 13.4 (4.4, 22.3) 0.004
Female 0 -
Nutritional status strata
Substantially malnourished 44.1 (55.2, 33.0) <0.0001
Mildly malnourished 27.4 (38.0, 16.9) <0.0001
Normally malnourished 0 -
H. pylori infection* time from enrollment
New infection 9.7 (15.6, 3.8) 0.001
Chronic infection 3.3 (8.7, 2.2) 0.2
Not infected 0 -
CI, conﬁdence interval.was 96 mm/year. Tomodel the effects of Helicobacter infections on
growth velocity, the regression model contained two interaction
terms between indicator variables for new and chronic Helico-
bacter infections and continuous variable for time from enroll-
ment. Age-adjusted growth velocity during follow-upwas reduced
in children with new Helicobacter infections by 9.7 (95% CI 3.8,
15.6) mm/year compared to controls, while the effect of chronic
infections wasweak and non-signiﬁcant (Table 3). Further analysis
(not shown in Table 3) demonstrated that age-adjusted growth
velocity in infected seronegative children (new infections) was
reduced by 6.4 (95% CI 0.0, 12.9) mm/year (p = 0.05) compared to
infected seropositive children (chronic infections). In stratiﬁed
regression analysis, the adjusted detrimental effects of new
Helicobacter infections on growth velocity were very similar in
boys and girls, 10.5 (95% CI 0.9, 21.9) mm/year and 9.0 (95% CI
2.2, 20.1) mm/year, respectively.
The effects of Helicobacter on ponderal growth were analyzed
using similar mixed effect regression models (except the effect of
age was modeled using a quadratic polynomial). The adjusted
detrimental effects of new and chronic Helicobacter infections on
ponderal growth velocitywere small and not signiﬁcant, 53 (95% CI
147, 253) g/year (p = 0.6) and 10 (95% CI 173, 193) g/year
(p = 0.9), respectively.
4. Discussion
The main ﬁnding of this study was that new Helicobacter
infections deﬁned as positive fecal antigen test and negative
serology were associated with reduced linear growth in young
children. The estimated deﬁcit in the average growth velocity
during one year of follow-up in children with new infections
compared to non-infected controls was almost 10 mm/year, which
translates into approximately 10% slower linear growth. There was
no evidence of catch-up growth in children with chronic
Helicobacter infection. These results show that Helicobacter
infections contributed substantially to the pronounced growth
deﬁcit in young Ecuadorian children from poor urban neighbor-
hoods.
The ﬁnding of this study is in agreement with previous research
in Colombia that also demonstrated the detrimental effect of
Helicobacter infection on growth being most pronounced right
after the infection.13 It could be speculated that chronic infection is
associated with a different pattern of gastric inﬂammation which
does not cause a detrimental effect on growth in children. IgG
seroconversion, which occurs several months post-infection in
children, can serve as a biomarker of the transition to the chronic
phase of infection. Akhiani et al.20 demonstrated that the
development of an anti-Helicobacter antibody response is
associated with reduced gastric inﬂammation but enhanced
colonization in animal models and speculated that anti-Helico-
bacter antibody may facilitate the persistence of this pathogen.
A.I. Egorov et al. / International Journal of Infectious Diseases 14 (2010) e788–e791 e791The detrimental effect of new Helicobacter infection on linear
growth velocity in these Ecuadorian children was almost twice the
5 mm/year effect previously observed in Colombian children.11
This discrepancymay be explained by different source populations
and, at least in part, a random sampling effect. The effect of
Helicobacter on ponderal growth in these Ecuadorian children was
small and non-signiﬁcant, which is consistent with the results of
previous research in Colombia.11,13
This study used a monoclonal fecal antigen ELISA test to detect
Helicobacter infections and serological IgG ELISA tests to further
classify infections as new (negative serology) or chronic (positive
serology) using a previously developed infection classiﬁcation
scheme.22–24 It has been demonstrated previously that the Hp
StARTM monoclonal antibody ELISA test for fecal Helicobacter
antigen can be used as a reliable indicator of Helicobacter infection
in children because it compares very well with invasive diagnostic
tests as well as the 13C-urea breath test, with sensitivity ranging
from 94.4% to 98.2% and speciﬁcity from 94.7% to 98.1%, depending
on the study.14,15,17
The 61% prevalence rate of Helicobacter infections in these
Ecuadorian children as determined by the Hp StARTM fecal antigen
test is similar to the 53% prevalence rate in 2-year-old Colombian
children as determined by the 13C-urea breath test,5 but higher
than the 23% prevalence rate reported in another group of
Colombian children who were, on average, approximately 4 years
of age.11
A limitation of this study was the lack of fecal Helicobacter
antigen testing at enrollment. This did not allow a more accurate
assessment of the timing of Helicobacter infection and duration of
its effects on growth. Moreover, severe episodes of diarrhea in
study participants were treated with antibiotics, altering the
natural history of the episode. Therefore, the lack of association
between episodes of diarrhea and growthmay not be generalizable
to the source population of low socioeconomic status Ecuadorian
children. Strengths of this study include the collection of detailed
growth data and the use of a socioeconomically homogeneous
source population. The results of this study provide further
evidence of detrimental developmental effects of Helicobacter in
young children living in poor economic conditions.
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